ABSCI CORPORATION - COMMON STOCK

Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference

15 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire

Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results

14 ноя 2023 15:05:00 Источник Nasdaq GlobeNewswire

Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases

14 ноя 2023 01:05:00 Источник Nasdaq GlobeNewswire

Absci to Participate in Upcoming Investor Conferences

26 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire

Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen

21 сен 2023 07:00:00 Источник Nasdaq GlobeNewswire

Absci to Host R&D Day on October 4, 2023

06 сен 2023 07:00:00 Источник Nasdaq GlobeNewswire

Absci to Participate in Upcoming Investor Conferences

28 авг 2023 15:05:00 Источник Nasdaq GlobeNewswire

Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results

14 авг 2023 07:02:00 Источник Nasdaq GlobeNewswire

Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer

14 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development

10 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

Absci to Participate in the UBS MedTech, Tools and Genomics Summit 2023

01 авг 2023 07:00:01 Источник Nasdaq GlobeNewswire

Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference

26 июл 2023 07:00:00 Источник Nasdaq GlobeNewswire

Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit

15 июн 2023 07:00:00 Источник Nasdaq GlobeNewswire

Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips

06 июн 2023 07:00:02 Источник Nasdaq GlobeNewswire

Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results

15 май 2023 15:05:00 Источник Nasdaq GlobeNewswire

University of Oxford’s Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies

11 май 2023 07:00:01 Источник Nasdaq GlobeNewswire

Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference

06 апр 2023 07:00:00 Источник Nasdaq GlobeNewswire

Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology

04 апр 2023 07:00:00 Источник Nasdaq GlobeNewswire

Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

30 мар 2023 15:05:00 Источник Nasdaq GlobeNewswire

Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation

23 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire